Medicinal Products

Tecartus

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Tecartus
Active Substance autologne T-stanice dobivene iz periferne krvi, odabrane pomoću čestica koje prepoznaju CD4 i CD8, aktivirane protutijelima protiv CD3 i CD28, transducirane retrovirusnim vektorom da bi eksprimirale CD28/CD3-zeta kimerični antigenski receptor protiv CD19 i uzgojene u kulturi
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01X
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Back